1Jia W P, Pang C, Chen L, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia, 2007,50:286-292.
4DeFronzo R A, Bergenstal R M, Cefalu W T, et al. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care, 2005,28 : 1922-1928.
5Defronzo R A. Is insulin resistance atherogenic? Possible mechanisms. Atheroscler Suppl, 2006,7 : 11-15.
6Horowitz M, Vilsbφll T, Zdravkovic M, et al. Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once daily human GLP-1 analogue, liraglutide. Diabetes Obes Metab, 2008,10 : 593-596.
7Schmitz O. The GLP-1 concept in the treatment of type 2 diabetes still standing at the gate of dawn? J Clin Endocrinol Metab, 2008,93:375 -377.
8Davidson J, Koro C, Arondekar B, et al. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmaeotherapy change patterns among type 2 diabetes mellitus patients. Clin Ther, 2008,30:287-293.
9Glasgow R E, Peeples M, Skovlund S E. Where is the patient in diabetes performance measures? The case for including patient centered and self-management measures. Diabetes Care, 2008,31 : 1046-1050.
10Bloomgarden Z T. Approaches to treatment of type 2 diabetes. Diabetes Care, 2008, 31:1697-1703.
二级参考文献27
1刘金塘.中国老年妇女人口变化趋势[J].人口研究,2001,25:50-59.
2Jia WP,Xiang KS,Chen L,et al.Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai,China Obes Rev,2002,3:157-165.
3Dormandy J,Heeck L,Vig S.Predicting which patients will develop chronic critical leg ischemia.Semin Vasc Surg,1999.12:138-141.
4Hiatt WR.Medical treatment of peripheral arterial disease and claudication.N Engl J Med,2001,344:1608-1621.
5Leng GC,Fowkes FG.The Edinburgh Claudication Questionnaire:an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys.J Clin Epidemiol,1992,45:1101-1109.
6Beks PJ,Mackaay AJ,de Neeling JN,et al.Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population:the Hoorn study.Diabetologia,1995,38:86-96.
7MacGregor AS,Price JF,Hau CM,et al.Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease.The Edinburgh artery study.Diabetes Care,1999,22:453-458.
8Premalatha G,Shanthirani S,Deepa R,et al.Prevalence and risk factors of peripheral vascular disease in a selected South Indian population:the Chennai urban population study.Diabetes Care,2000,23:1295-1300.
9Thomas GN,Critchley JA,Tomlinson B,et al.Peripheral vascular disease in type 2 diabetic Chinese patients:associations with metabolic indices,concomitant vascular disease and genetic factors.Diabet Med,2003,20:988-995.
10Beach KW,Bedford GR,Bergenlin RO,et al.Progression of lower-extremity arterial occlusive disease in type Ⅱ diabetes mellitus.Diabetes Care,1988,11:464-472.
